Results 1 to 10 of about 233,561 (109)

Clinical Application of Circulating Tumor Cells and Circulating Endothelial Cells in Predicting Bladder Cancer Prognosis and Neoadjuvant Chemosensitivity [PDF]

Frontiers in Oncology, 2022
PurposeTo investigate the role of circulating rare cells (CRCs), namely, circulating tumor cells (CTCs) and circulating endothelial cells (CECs), in aiding early intervention, treatment decision, and prognostication in bladder cancer.MethodsA total of ...
Xiao Yang, Jiancheng Lv, Zijian Zhou, Dexiang Feng, Rui Zhou, Rui Zhou, Baorui Yuan, Qikai Wu, Hao Yu, Jie Han, Qiang Cao, Min Gu, Pengchao Li, Haiwei Yang, Qiang Lu   +14 more
doaj   +4 more sources

Pulmonary arterial hypertension in children with congenital heart disease: a deeper look into the role of endothelial progenitor cells and circulating endothelial cells to assess disease severity [PDF]

Frontiers in Pediatrics, 2023
Endothelial progenitor cells and circulating endothelial cells have been proposed as useful markers of severity and disease progression in certain vascular diseases, including pulmonary arterial hypertension. Our study focused on evaluating the levels of
Juan Calderón-Colmenero, Felipe Massó, Héctor González-Pacheco, Julio Sandoval, Carlos Guerrero, Jorge Cervantes-Salazar, José A. García-Montes, Araceli Paéz, Gabriela I. Pereira-López, Carlos Zabal-Cerdeira, Juan Pablo Sandoval   +10 more
doaj   +2 more sources

Intermediate Monocytes and Circulating Endothelial Cells: Interplay with Severity of Atherosclerosis in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus [PDF]

Biomedicines, 2023
The aim was to investigate the association of monocyte heterogeneity and presence of circulating endothelial cells with the severity of coronary atherosclerosis in patients with coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM).
Irina V. Kologrivova, Tatiana E. Suslova, Olga A. Koshelskaya, Elena S. Kravchenko, Olga A. Kharitonova, Ekaterina A. Romanova, Alexandra I. Vyrostkova, Alla A. Boshchenko   +7 more
doaj   +2 more sources

High levels of endothelial progenitor cells and circulating endothelial cells in patients with Behçet's disease and their relationship to disease activity [PDF]

Anais Brasileiros de Dermatologia, 2019
: Background: Behçet's disease is a multisystemic vasculitis, associated with vascular endothelial dysfunction. Currently, the prognosis is unpredictable, because there is still no valid laboratory marker indicating the disease activity in Behçet's ...
Deniz Aksu Arica, Burak Akşan, Asim Örem, Buket Akcan Altinkaynak, Savaş Yayli, Mehmet Sönmez   +5 more
doaj   +2 more sources

Circulating Endothelial Cells, Circulating Endothelial Progenitor Cells, and Circulating Microparticles in Type 1 Diabetes Mellitus [PDF]

Clinical and Applied Thrombosis/Hemostasis, 2019
Background and Aim: Hyperglycemia in type 1 diabetes (T1D) is accompanied by endothelial cell dysfunction which is known to contribute to the pathogenesis of cardiovascular disorders. The aim of the current study was to explore the profile of circulating
Asmaa M. Zahran MD, Ismail L. Mohamed MD, Osama M. El Asheer MD, Deiaaeldin M. Tamer MD, Mohamed G. M. Abo-ELela MD, Mona H. Abdel-Rahim MD, Omnia H. B. El-Badawy MD, Khalid I. Elsayh MD   +7 more
doaj   +2 more sources

Circulating Endothelial Cells, Endothelial Progenitor Cells, and Endothelial Microparticles in Cancer

Neoplasia: An International Journal for Oncology Research, 2006
Cancer, a proliferative disease hallmarked by abnormal cell growth and spread, is largely dependent on tumor neoangiogenesis, with evidence of vascular endothelial dysfunction.
P.K.Y. Goon, G.Y.H. Lip, C.J. Boos, P.S. Stonelake, A.D. Blann   +4 more
doaj   +3 more sources

No Differences in Levels of Circulating Progenitor Endothelial Cells or Circulating Endothelial Cells Among Patients Treated With Ticagrelor Compared With Clopidogrel During Non–ST‐Segment–Elevation Myocardial Infarction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background Ticagrelor use during acute coronary syndromes demonstrated a decrease in all‐cause mortality in the PLATO (Platelet Inhibition and Patient Outcomes) trial.
Alejandro Diego‐Nieto, Maria B. Vidriales, Norberto Alonso‐Orcajo, Jose C. Moreno‐Samos, Francisco Martin‐Herrero, Raul Carbonell, Belen Cid, Ignacio Cruz‐Gonzalez, Javier C. Martin‐Moreiras, Carlos Cuellas, Cristina Pascual, Maria Lopez‐Benito, Pedro L. Sanchez, Felipe Fernandez‐Vazquez, Armando Perez de Prado   +14 more
doaj   +3 more sources

Isolation of circulating endothelial cells provides tool to determine endothelial cell senescence in blood samples [PDF]

Scientific Reports
Circulating endothelial cells (CEC) are arising as biomarkers for vascular diseases. However, whether they can be utilized as markers of endothelial cell (EC) senescence in vivo remains unknown.
Katrin Kalies, Kai Knöpp, Leonie Wurmbrand, Laura Korte, Jochen Dutzmann, Claudia Pilowski, Susanne Koch, Daniel Sedding   +7 more
doaj   +2 more sources

Angiogenesis and Ovarian Cancer: What Potential Do Different Subtypes of Circulating Endothelial Cells Have for Clinical Application? [PDF]

Int J Mol Sci
Asante DB, Tierno D, Woode M, Scaggiante B.   +3 more
europepmc   +2 more sources

Does erythropoietin therapy affect circulating endothelial cells in hemodialysis patients?

Український Журнал Нефрології та Діалізу, 2020
Anemia is a common complication of chronic kidney disease (CKD). The most common cause of anemia in CKD is erythropoietin deficiency; and the most important cause of mortality in CKD patients is atherosclerotic vascular complications which are ...
T. Bulduk, A. U. Yalcin, O. M. Akay, S. G. Ozkurt, H. U. Teke, G. Sahin, G. Temiz, G. Demirel   +7 more
doaj   +1 more source